Sustained Efficacy of Oteseconazole in Women with Recurrent Vulvovaginal Candidiasis

20251 citationsJournal Article

Authors

Samuel Lederman · New Covenant International

Ryan Sobel · Thomas Jefferson University

Stacey Curelop · Mycovia Pharmaceuticals (United States)

Stephen Brand · Mycovia Pharmaceuticals (United States)

Abstract

During the 48-week extension study, 1.4% of previously randomized subjects experienced a culture-positive recurrence of symptomatic vulvovaginal candidiasis, demonstrating a continued long-term protective effect of oteseconazole.

Topics & Keywords

Reproductive tract infections research Parasites and Host Interactions Syphilis Diagnosis and Treatment

Publication Details

Published in: Journal of Women s Health

Volume 35, Issue 3, pp. 334-339

DOI: 10.1177/15409996251394811

Field-Weighted Citation Impact: 1.22

Command Palette

Sustained Efficacy of Oteseconazole in Women with Recurrent Vulvovaginal Candidiasis

Authors

Abstract

Topics & Keywords

Publication Details